Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
2 hours ago
0
0
A Mayo Clinic study published in JAMA Network Open found that bringing some or all clinical trial-related activities directly to patients can help overcome barriers that prevent many people from participating. Increased participation ...
3 hours ago
0
0
In a phase 2 clinical trial, Mass General Brigham Cancer Institute researchers found that the oral drug avatrombopag was safe and effective in managing persistent chemotherapy-induced thrombocytopenia (CIT) in more than half ...
2 hours ago
0
1
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method, published June 30 in Leukemia, compares the physical locations ...
7 hours ago
0
3
Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of ...
7 hours ago
0
1
A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor their progress throughout treatment, ...
7 hours ago
0
2
It has long been suspected that endothelial cells, the specialized cells lining the inner walls of blood vessels, play a key role in determining how the body's immune system responds to tumors. Researchers at the German Cancer ...
9 hours ago
0
1
Researchers have found that, with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use different criteria to identify patients with poor chances of survival. The study was published online ...
16 hours ago
0
3
For decades, pathologists have diagnosed and graded breast cancer by looking at tissue samples under a microscope, searching for telltale signs of disorder in the structure of cells and tissues. Now, researchers at Columbia ...
Jul 19, 2026
0
16
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies. It's a major development for this type of immunotherapy, which has been used ...
Jul 19, 2026
0
9
